The individual's signature of telomere length distribution.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 01 2019
Historique:
received: 25 05 2018
accepted: 08 11 2018
entrez: 26 1 2019
pubmed: 27 1 2019
medline: 11 8 2020
Statut: epublish

Résumé

Mean telomere length in human leukocyte DNA samples reflects the different lengths of telomeres at the ends of the 23 chromosomes and in an admixture of cells. However, only rudimentary information is available regarding the distribution of telomere lengths in all chromosomes and the different cell types in leukocyte samples. Understanding the configuration of leukocyte telomere length distribution (LTLD) could be helpful in capturing intrinsic elements that are not provided by the mean leukocyte telomere length (mLTL). The objective of this study was to analyse LTLD and its temporal variation in adults. Leukocyte samples were donated on two occasions (8 years apart) by 72 participants in the ADELAHYDE study. Telomere length was measured by Southern blotting of the terminal restriction fragments. Individuals with comparable mLTLs displayed different shapes of LTLDs. Inter-individual variation in LTLD shape was much larger than intra-individual variation in LTLD shape between baseline and follow-up leukocyte samples. These results show an important individual stability of LTLD shape over time indicating that each individual has a characteristic LTLD signature.

Identifiants

pubmed: 30679552
doi: 10.1038/s41598-018-36756-8
pii: 10.1038/s41598-018-36756-8
pmc: PMC6345926
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

685

Références

Cell. 2001 Oct 5;107(1):67-77
pubmed: 11595186
Lancet. 2003 Feb 1;361(9355):393-5
pubmed: 12573379
Nature. 2003 Nov 13;426(6963):194-8
pubmed: 14608368
Mol Biol Cell. 2004 Aug;15(8):3709-18
pubmed: 15181152
Neurobiol Aging. 2006 Jul;27(7):941-5
pubmed: 16046031
Nat Protoc. 2006;1(5):2365-76
pubmed: 17406480
Indian J Med Res. 2007 Mar;125(3):441-50
pubmed: 17496367
Mol Cell Biochem. 2007 Oct;304(1-2):353-60
pubmed: 17594061
Diabetes Care. 2007 Nov;30(11):2909-15
pubmed: 17666463
Stroke. 2009 Apr;40(4):1229-36
pubmed: 19246701
Science. 2009 Nov 13;326(5955):948-52
pubmed: 19965504
Aging Cell. 2010 Jun;9(3):383-97
pubmed: 20331440
Nat Protoc. 2010 Sep;5(9):1596-607
pubmed: 21085125
Nucleic Acids Res. 2011 Nov 1;39(20):e134
pubmed: 21824912
Arthritis Res Ther. 2012 Jan 18;14(1):R12
pubmed: 22257826
PLoS Genet. 2012;8(5):e1002696
pubmed: 22661914
Neuromolecular Med. 2013 Mar;15(1):25-48
pubmed: 23161153
Nature. 1990 May 31;345(6274):458-60
pubmed: 2342578
Eur J Epidemiol. 2013 Feb;28(2):181-7
pubmed: 23430034
Nat Commun. 2013;4:1597
pubmed: 23511462
Aging Cell. 2013 Aug;12(4):615-21
pubmed: 23601089
Genetics. 2013 Aug;194(4):847-57
pubmed: 23733785
Aging Clin Exp Res. 2013 Jun;25(3):231-8
pubmed: 23740586
Mech Ageing Dev. 2013 Sep;134(9):367-72
pubmed: 23872258
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):527-31
pubmed: 23946336
BMJ. 2014 Jul 08;349:g4227
pubmed: 25006006
Mol Cell Biochem. 2014 Nov;396(1-2):129-35
pubmed: 25060906
Int J Epidemiol. 2015 Oct;44(5):1673-83
pubmed: 25239152
Circ Cardiovasc Genet. 2015 Feb;8(1):82-90
pubmed: 25406241
J Natl Cancer Inst. 2015 Apr 10;107(6):djv074
pubmed: 25862531
Int J Epidemiol. 2015 Oct;44(5):1683-6
pubmed: 26403812
Elife. 2015 Oct 15;4:null
pubmed: 26468615
Exp Gerontol. 2016 Mar;75:53-5
pubmed: 26772888
Int J Cardiol. 2016 Mar 15;207:157-63
pubmed: 26803233
Diabetologia. 2016 Jun;59(6):1258-65
pubmed: 27020448
J Am Med Dir Assoc. 2017 May 1;18(5):451.e13-451.e25
pubmed: 28279605
Hypertension. 2017 Aug;70(2):420-425
pubmed: 28630210
FASEB J. 2018 Jan;32(1):529-534
pubmed: 28855279
Nat Commun. 2017 Nov 7;8(1):1356
pubmed: 29116081
Circ Res. 2018 Feb 16;122(4):616-623
pubmed: 29242238
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
Hum Genet. 1998 Jun;102(6):640-3
pubmed: 9703424

Auteurs

Simon Toupance (S)

Université de Lorraine, Inserm, DCAC, F-54000, Nancy, France.
Université de Lorraine, CHRU-Nancy, Pôle "Maladies du Vieillissement, Gérontologie et Soins Palliatifs", F-54000, Nancy, France.
Nancyclotep-GIE, F-54000, Nancy, France.

Denis Villemonais (D)

Université de Lorraine, Ecole des Mines, F-54000, Nancy, France.
Université de Lorraine, CNRS, Inria, IECL, F-54000, Nancy, France.

Daphné Germain (D)

Université de Lorraine, Ecole des Mines, F-54000, Nancy, France.

Anne Gegout-Petit (A)

Université de Lorraine, CNRS, Inria, IECL, F-54000, Nancy, France.

Eliane Albuisson (E)

Université de Lorraine, CNRS, Inria, IECL, F-54000, Nancy, France.
Université de Lorraine, CHRU de Nancy, BIOBASE, Pôle S2R, Nancy, F-54000, France.
Université de Lorraine, InSciDenSe, F-54000, Nancy, France.

Athanase Benetos (A)

Université de Lorraine, Inserm, DCAC, F-54000, Nancy, France. a.benetos@chru-nancy.fr.
Université de Lorraine, CHRU-Nancy, Pôle "Maladies du Vieillissement, Gérontologie et Soins Palliatifs", F-54000, Nancy, France. a.benetos@chru-nancy.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH